Kenvue Inc. (NYSE:KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue, today announced that its Board of Directors has declared a dividend payable in the third quarter of 2023 of $0.20 per share on the Company's common stock.

"The decision by our Board of Directors to declare a dividend further underscores the confidence we have in the strength of our portfolio of iconic brands to drive profitable growth and durable cash flow generation over the long term," said Thibaut Mongon, Chief Executive Officer and Director. "The dividend is an important component of our disciplined capital allocation strategy and our plan to deliver sustained value creation for all of our stockholders."

The third quarter dividend is payable on September 7, 2023, to shareholders of record as of the close of business on August 28, 2023.

Second Quarter 2023 Financial Results and Conference Call Information

Kenvue also today announced its financial results for the second quarter ending July 2, 2023. As previously announced, company will host a conference call and webcast at 7:30 a.m. Eastern Time to discuss its second quarter results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or 201-689-8779 from international locations. A live webcast of the conference call will be available at https://investors.kenvue.com. A replay will be available approximately two hours after the live event.

About Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno^®, BAND-AID^® Brand Adhesive Bandages, Johnson's^®, Listerine^®, Neutrogena^®, and Tylenol^®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Cautions Concerning Forward-Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding future operating and financial performance. Forward-looking statements may be identified by the use of words such as "plans," "expects," "will," "anticipates," "estimates" and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates.

A list and descriptions of risks, uncertainties and other factors can be found in Kenvue's filings with the Securities and Exchange Commission, including its registration statement on Form S-1 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230720695902/en/